OncoSec Medical Incorporated (ONCS) will report its next earnings on Sep 19 AMC. The company reported the earnings of $-0.2/Share in the last quarter where the estimated EPS by analysts was $-0.19/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -5.3%.
Many analysts are providing their Estimated Earnings analysis for OncoSec Medical Incorporated and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.17/share. These analysts have also projected a Low Estimate of $-0.18/share and a High Estimate of $-0.15/share.
Some buy side analysts are also providing their Analysis on OncoSec Medical Incorporated, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for OncoSec Medical Incorporated might touch $5 high while the Average Price Target and Low price Target is $4.67 and $4 respectively.
The Relative Volume of the company is 2.54 and Average Volume (3 months) is 576.76 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -140%. The Return on Equity (ROE) value stands at -173.9%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, OncoSec Medical Incorporated currently shows a Weekly Performance of -1.34%, where Monthly Performance is -6.96%, Quarterly performance is 2.8%, 6 Months performance is -15.52% and yearly performance percentage is 44.12%. Year to Date performance value (YTD perf) value is -9.54%. The Stock currently has a Weekly Volatility of 6.05% and Monthly Volatility of 6.27%.